Atopic Dermatitis

Immunology·MeSH: Dermatitis, Atopic

Prevalence

7000.0 / 100K

Incidence

800.0 / 100K/yr

102 drugs in development·51 companies·93 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
cibinqo	PFIZER INC (PFE)
doxepin	Amneal Pharmaceuticals, Inc. (AMRX)
Ebglyss	ELI LILLY & Co (LLY)
Ebglyss®	ELI LILLY & Co (LLY)
Elidel authorized generic	Bausch Health Companies Inc. (BHC)
hydrocortisone	Aptinyx Inc. (APTX)
methylprednisolone	Amneal Pharmaceuticals, Inc. (AMRX)
Olumiant	ELI LILLY & Co (LLY)
Olumiant®	ELI LILLY & Co (LLY)
psoria-light	WELLNESS CENTER USA, INC. (WCUI)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
zenrelia	Elanco Animal Health Inc (ELAN)
ZORYVE (roflumilast) cream 0.15%	Arcutis Biotherapeutics, Inc. (ARQT)
ZORYVE (roflumilast) cream 0.3%	Arcutis Biotherapeutics, Inc. (ARQT)
ZORYVE cream (ARQ-151)	Arcutis Biotherapeutics, Inc. (ARQT)

Phase 3(19)

Drug	Company
ADSTEM Inj.	Accustem Sciences Inc. (ACUT)
ADSTEM Inj.	Cidara Therapeutics, Inc. (CDTX)
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)
Dupilumab	AbbVie Inc. (ABBV)
Dupilumab 300mg Dose	AbbVie Inc. (ABBV)
IBI3002	Crinetics Pharmaceuticals, Inc. (CRNX)
kind-016	Kindred Biosciences, Inc. (KIN)
Lebrikizumab	ELI LILLY & Co (LLY)
Lutikizumab	AbbVie Inc. (ABBV)
pg-011gel	TG THERAPEUTICS, INC. (TGTX)
Roflumilast Cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)
soquelitinib	Corvus Pharmaceuticals, Inc. (CRVS)
soquelitinib (CPI-818)	Corvus Pharmaceuticals, Inc. (CRVS)
Upadacitinib 15mg Dose	AbbVie Inc. (ABBV)
Upadacitinib 30mg Dose	AbbVie Inc. (ABBV)
vehicle	TG THERAPEUTICS, INC. (TGTX)
Vehicle cream	Organon & Co. (OGN)
Vehicle Cream	Arcutis Biotherapeutics, Inc. (ARQT)
zl-1503	Zai Lab Ltd (ZLAB)

Phase 2(31)

Drug	Company
ADX-248	Aldeyra Therapeutics, Inc. (ALDX)
ANB032	ANAPTYSBIO, INC (ANAB)
ARQ-151 cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)
ATI-045	Aclaris Therapeutics, Inc. (ACRS)
ATI-052	Aclaris Therapeutics, Inc. (ACRS)
ATI-1777	Aclaris Therapeutics, Inc. (ACRS)
ATI-2138	Aclaris Therapeutics, Inc. (ACRS)
Bosakitug (ATI-045)	Aclaris Therapeutics, Inc. (ACRS)
camoteskimab	Horizon Therapeutics Public Ltd Co (HZNP)
Dupilumab	Crinetics Pharmaceuticals, Inc. (CRNX)
E6005 ointment	Organon & Co. (OGN)
edp1815	Evelo Biosciences, Inc. (EVLO)
eq121	EQRx, Inc. (EQRX)
evo301	Evommune, Inc. (EVMN)
galvokimig	POINT Biopharma Global Inc. (PNT)
galvokimig	GT Biopharma, Inc. (GTBP)
gia632	Novartis AG (NVS)
GIA632	Novartis AG (NVS)
HY209GEL Active	Valneva SE (VALN)
KT-474/SAR444656	Kymera Therapeutics, Inc. (KYMR)
KT-621	Kymera Therapeutics, Inc. (KYMR)
Lepzacitinib (ATI-1777)	Aclaris Therapeutics, Inc. (ACRS)
prn473	Principia Biopharma Inc. (PRNB)
Rezpegaldesleukin	NEKTAR THERAPEUTICS (NKTR)
rocatinlimab	AMGEN INC (AMGN)
rpt193	RAPT Therapeutics, Inc. (RAPT)
sar444656	Sanofi (SNY)
sim0278	NYMOX PHARMACEUTICAL CORP (NYMXF)
tapinarof cream, 1%	Organon & Co. (OGN)
TRIV-509	Valneva SE (VALN)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

Phase 1(11)

Drug	Company
apg279	Apogee Therapeutics, Inc. (APGE)
APG777	Apogee Therapeutics, Inc. (APGE)
APG990	Apogee Therapeutics, Inc. (APGE)
ARQ-234	Arcutis Biotherapeutics, Inc. (ARQT)
biolexa	Hoth Therapeutics, Inc. (HOTH)
Dupilumab	Apogee Therapeutics, Inc. (APGE)
E6005	Organon & Co. (OGN)
E6005 0.05%	Organon & Co. (OGN)
E6005 0.2%	Organon & Co. (OGN)
gb-7624	Generate Biomedicines Inc. (GENB)
star-0310	BIOCRYST PHARMACEUTICALS INC (BCRX)

Preclinical(9)

Drug	Company
APG222	Apogee Therapeutics, Inc. (APGE)
atopic dermatitis compound	PHIBRO ANIMAL HEALTH CORP (PAHC)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
EPS-3903	ENANTA PHARMACEUTICALS INC (ENTA)
IMC-U120AI	Immunocore Holdings plc (IMCR)
kind-025	Kindred Biosciences, Inc. (KIN)
kind-032	Kindred Biosciences, Inc. (KIN)
nanocyclo	IMMUNE PHARMACEUTICALS INC (IMNP)
Oral IL-4R alpha antagonist	Protagonist Therapeutics, Inc (PTGX)

Unknown(3)

Drug	Company
follow-up period after dermocorticoid treatment alone	CEN BIOTECH INC (CENB)
img-007	ImageneBio, Inc. (IMA)
treatment period with dermocorticoid alone	CEN BIOTECH INC (CENB)

BLA Filed(1)

Drug	Company
ZORYVE (roflumilast) cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)

Phase 1/Phase 2(3)

Phase 4(10)

Drug	Company
Dupilumab	Clearside Biomedical, Inc. (CLSDQ)
Hydrocortisone	Clearside Biomedical, Inc. (CLSDQ)
Onabotulinum Toxin Type A - Phase 1b	Revance Therapeutics, Inc. (RVNC)
Onabotulinum Toxin Type A - Phase 2	Revance Therapeutics, Inc. (RVNC)
Tapinarof	Organon & Co. (OGN)
Triamcinolone Acetonide	Clearside Biomedical, Inc. (CLSDQ)
Upadacitinib	AbbVie Inc. (ABBV)
Vanicream- Active	Clearside Biomedical, Inc. (CLSDQ)
Vanicream- Dupilumab-naïve	Clearside Biomedical, Inc. (CLSDQ)
Vanicream- Experienced Dupilumab	Clearside Biomedical, Inc. (CLSDQ)

BioSniper tracks 102 drugs in development for Atopic Dermatitis across 51 companies.

There are 93 clinical trials targeting Atopic Dermatitis tracked by BioSniper.

The estimated prevalence of Atopic Dermatitis is approximately 7000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.